Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00846794
Other study ID # SR1219080169
Secondary ID 400
Status Completed
Phase N/A
First received February 12, 2009
Last updated September 14, 2016
Start date February 2009
Est. completion date March 2010

Study information

Verified date September 2016
Source Logan College of Chiropractic
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

This research is designed to study the reliability of the results of an AcuGraph in college students and faculty members with reported digestive symptoms


Description:

The specific aim of the study is to test the reliability of the AcuGraph in subjects with irritable bowel syndrome (IBS). The hypothesis is that the AcuGraph will be a reliable method to identify disorders in subjects.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date March 2010
Est. primary completion date March 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Subjects will be required to answer a questionnaire evaluating for a percentage of digestive disorders "disability" based on the subject's answers. If a participant's answers do not qualify as a disability, they will be assigned to the asymptomatic group and will still be examined with an AcuGraph to provide normative data.

Exclusion Criteria:

- heart condition

- kidney disorder

- thyroid disorders

- diabetes

- chronic disease or illness

- neurological diseases

- skin or bleeding disorders

- pregnant

- currently taking drugs or nutritional supplements

- pacemaker and/or

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional


Locations

Country Name City State
United States Logan University, College of Chiropractic Chesterfield Missouri

Sponsors (1)

Lead Sponsor Collaborator
Logan College of Chiropractic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary AcuGraph: computerized device to analyze & document the energetic status of the acupuncture meridians At examination No
Secondary IBS Questionnaire At examination No
See also
  Status Clinical Trial Phase
Completed NCT03720314 - Microbiota Profiling in IBS
Recruiting NCT06166563 - Exercise, Irritable Bowel Syndrome and Fibromyalgia N/A
Completed NCT05213910 - Study of a Management Strategy of Functional Bowel Disordes Related to Irritable Bowel Syndrome (IBS) With a Mixture of 8 Microbiotic Strains N/A
Recruiting NCT05985018 - Traditional Dietary Advice Vs. Mediterranean Diet in IBS N/A
Completed NCT04486469 - Efficacy of Physiotherapy Techniques on Irritable Bowel Syndrome (IBS). Pilot Study. N/A
Completed NCT06407609 - Positive Outcomes of the Supplementation With Lecithin-based Delivery Form of Curcuma Longa and of Boswellia Serrata in IBS N/A
Completed NCT04656730 - Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas Phase 4
Completed NCT04145856 - Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico Phase 4
Recruiting NCT04138225 - The Ecological Role of Yeasts in the Human Gut
Active, not recruiting NCT03586622 - One Year Home Monitoring and Treatment of IBS Patients N/A
Completed NCT05207618 - Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant N/A
Not yet recruiting NCT06369753 - Visible Abdominal Distension N/A
Not yet recruiting NCT05157867 - In Vivo Effects of Amylase Trypsin Inhibitors N/A
Not yet recruiting NCT05100719 - The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION) N/A
Recruiting NCT05001997 - Effects of Lactose-free Dairy Products on Athletes With Irritable Bowel Syndrome N/A
Recruiting NCT02953171 - Probiotics in the Treatment of Irritable Bowel Syndrome N/A
Completed NCT02977975 - Lacto-fermented Sauerkraut in the Treatment of Irritable Bowel Syndrome N/A
Completed NCT03266068 - Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
Completed NCT02980406 - The Role of FODMAPs in Upper GI Effects, Colonic Motor Activity and Gut-brain Signaling at the Behavioral Level N/A
Completed NCT03318614 - Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster Phase 2/Phase 3